セッション情報

企業共催シンポジウム

第59回・2014年・神戸
企業共催シンポジウム
企業共催シンポジウム2
DOPPS Symposium in Japan(Dialysis Outcomes & Practice Patterns Study)
[共催] 協和発酵キリン株式会社
開催回
第59回・2014年・神戸

The International Dialysis Outcomes and Practice Patterns Study (DOPPS): Informing the World-wide Nephrology Community on Hemodialysis Practices Associated with Best Patient Outcomes

演題番号 : KS-2-1

Francesca Tentori:1

1:Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA

The International Dialysis Outcomes and Practice Patterns Study (DOPPS): Informing the World-wide Nephrology Community on Hemodialysis Practices Associated with Best Patient Outcomes

Patient-Doctor Contact and Impact on Clinical Outcomes of HD patients.

演題番号 : KS-2-2

Laura Mariani:1

1:Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA

Patient-Doctor Contact and Impact on Clinical Outcomes of HD patients.

Association of Blood Pressure with All-Cause Mortality and Stroke in Japanese Hemodialysis Patients: The Japan Dialysis Outcomes and Practice Pattern Study

演題番号 : KS-2-3

Masaaki Inaba:1、Angelo Karaboyas:2、Bruce M. Robinson:2、J-Dopps Steering Committee:3

1:Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan、2:Arbor Research Collaborative for Health, Ann Arbor, MI, USA、3:J-DOPPS Study Group

Association of Blood Pressure with All-Cause Mortality and Stroke in Japanese Hemodialysis Patients: The Japan Dialysis Outcomes and Practice Pattern Study

Update on Anemia Management: Japan and Worldwide DOPPS

演題番号 : KS-2-4

Laura Mariani:1

1:Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA

Update on Anemia Management: Japan and Worldwide DOPPS

Time-Dependent Resistance to Erythropoiesis-Stimulating Agent and Mortality in Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study

演題番号 : KS-2-5

Tetsuya Fujikawa:1

1:Yokohama City University

Time-Dependent Resistance to Erythropoiesis-Stimulating Agent and Mortality in Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study

Trends and Outcomes in Mineral and Bone Disorder Management in Hemodialysis Patients: Results from the DOPPS

演題番号 : KS-2-6

Francesca Tentori:1

1:Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA

Trends and Outcomes in Mineral and Bone Disorder Management in Hemodialysis Patients: Results from the DOPPS

Addition of sevelamer hydrochloride associates with improved survival on hemodialysis: the Japan Dialysis Outcomes and Practice Patterns Study (J-DOPPS)

演題番号 : KS-2-7

Hirotaka Komaba:1、Masatomo Taniguchi:2、Suguru Yamamoto:3、Masafumi Fukagawa:1

1:Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine、2:Departments of Medicine & Clinical Science, Graduate School of Medical Sciences, Kyushu University、3:Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Science

Addition of sevelamer hydrochloride associates with improved survival on hemodialysis: the Japan Dialysis Outcomes and Practice Patterns Study (J-DOPPS)